Enanta Pharmaceuticals, Inc. (ENTA)
12.11
-0.09
(-0.74%)
USD |
NASDAQ |
Sep 21, 16:00
12.11
0.00 (0.00%)
After-Hours: 20:00
Enanta Pharmaceuticals Price : 12.11 for Sept. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 21, 2026 | 12.28 | 12.28 | 11.94 | 12.11 | 217213.0 |
| Sep 18, 2026 | 12.49 | 12.60 | 12.19 | 12.20 | 428245.0 |
| Sep 17, 2026 | 12.67 | 12.84 | 12.48 | 12.52 | 277683.0 |
| Sep 16, 2026 | 12.33 | 12.92 | 12.33 | 12.70 | 267530.0 |
| Sep 15, 2026 | 13.07 | 13.07 | 12.16 | 12.29 | 284879.0 |
| Sep 14, 2026 | 12.81 | 13.13 | 12.79 | 13.12 | 280241.0 |
| Sep 11, 2026 | 12.83 | 13.04 | 12.59 | 12.96 | 289137.0 |
| Sep 10, 2026 | 13.09 | 13.21 | 12.44 | 12.70 | 312792.0 |
| Sep 09, 2026 | 13.50 | 13.51 | 13.09 | 13.24 | 192953.0 |
| Sep 08, 2026 | 13.91 | 13.91 | 13.43 | 13.50 | 158196.0 |
| Sep 04, 2026 | 13.92 | 14.22 | 13.45 | 14.08 | 233451.0 |
| Sep 03, 2026 | 14.17 | 14.29 | 13.85 | 14.02 | 239350.0 |
| Sep 02, 2026 | 13.56 | 14.19 | 13.48 | 14.09 | 251784.0 |
| Sep 01, 2026 | 13.34 | 13.64 | 13.24 | 13.51 | 217296.0 |
| Aug 31, 2026 | 13.52 | 13.60 | 13.12 | 13.33 | 286516.0 |
| Aug 28, 2026 | 13.72 | 13.91 | 13.47 | 13.60 | 155915.0 |
| Aug 27, 2026 | 14.08 | 14.18 | 13.76 | 13.80 | 280234.0 |
| Aug 26, 2026 | 14.00 | 14.37 | 13.75 | 14.15 | 156203.0 |
| Aug 25, 2026 | 14.06 | 15.05 | 14.02 | 14.08 | 407079.0 |
| Aug 24, 2026 | 13.44 | 14.27 | 12.83 | 14.10 | 357439.0 |
| Aug 21, 2026 | 13.27 | 13.70 | 13.09 | 13.47 | 335246.0 |
| Aug 20, 2026 | 13.42 | 13.50 | 12.93 | 13.13 | 194821.0 |
| Aug 19, 2026 | 13.51 | 13.63 | 13.16 | 13.51 | 187392.0 |
| Aug 18, 2026 | 12.80 | 13.42 | 12.80 | 13.30 | 196630.0 |
| Aug 17, 2026 | 13.13 | 13.32 | 12.59 | 12.83 | 314792.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Perspective Therapeutics, Inc. | 2.97 |
| AbbVie, Inc. | 264.48 |
| Coherus Oncology, Inc. | 1.37 |
| BridgeBio Pharma, Inc. | 66.58 |
| RenovoRx, Inc. | 1.67 |
Price Related Metrics
| PS Ratio | 5.022 |
| Price to Book Value | 3.489 |
| Earnings Yield | -19.91% |
| Market Cap | 352.64M |